Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: memo - Magazine of European Medical Oncology 2/2014

01.05.2014 | review

Follow-up in non-small-cell lung cancer

verfasst von: MD, PhD Sacha I. Rothschild, MD Didier Lardinois, MD Jens Bremerich, MD Michael Tamm, MD Lukas Bubendorf, MD Alexandros Papachristofilou, MSc Hansruedi Stoll, MD Alfred Zippelius

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten
share
TEILEN

Abstract

The major impetus for structured follow-up after primary treatment of localized non-small-cell lung cancer is both early detection and re-treatment of recurrent disease with a curative intent, and early detection and treatment of a secondary primary tumor. In patients with lung cancer, the significance of intensive follow-up is still under debate.
Literatur
1.
Zurück zum Zitat Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30. PubMedCrossRef Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30. PubMedCrossRef
2.
Zurück zum Zitat Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111(6):1710–7. PubMedCrossRef Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111(6):1710–7. PubMedCrossRef
3.
Zurück zum Zitat Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, Ginsberg RJ. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995;109(1):120–9. PubMedCrossRef Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, Ginsberg RJ. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995;109(1):120–9. PubMedCrossRef
4.
Zurück zum Zitat al-Kattan K, Sepsas E, Fountain SW, Townsend ER. Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg. 1997;12:380–4. PubMedCrossRef al-Kattan K, Sepsas E, Fountain SW, Townsend ER. Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg. 1997;12:380–4. PubMedCrossRef
5.
Zurück zum Zitat Martin J, Ginsberg RJ, Venkatraman ES, Bains MS, Downey RJ, Korst RJ, Kris MG, Rusch VW. Long-term results of combined-modality therapy in resectable non-small-cell lung cancer. J Clin Oncol. 2002;20:1989–95. PubMedCrossRef Martin J, Ginsberg RJ, Venkatraman ES, Bains MS, Downey RJ, Korst RJ, Kris MG, Rusch VW. Long-term results of combined-modality therapy in resectable non-small-cell lung cancer. J Clin Oncol. 2002;20:1989–95. PubMedCrossRef
6.
Zurück zum Zitat The Ludwig Lung Cancer Study Group. Patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung. Ann Surg. 1987;205(1):67–71. CrossRef The Ludwig Lung Cancer Study Group. Patterns of failure in patients with resected stage I and II non-small-cell carcinoma of the lung. Ann Surg. 1987;205(1):67–71. CrossRef
7.
Zurück zum Zitat Sugimura H, Nichols FC, Yang P, Allen MS, Cassivi SD, Deschamps C, Williams BA, Pairolero PC. Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg. 2007;83(2):409–17. Discussion 417–8. PubMedCrossRef Sugimura H, Nichols FC, Yang P, Allen MS, Cassivi SD, Deschamps C, Williams BA, Pairolero PC. Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg. 2007;83(2):409–17. Discussion 417–8. PubMedCrossRef
8.
Zurück zum Zitat Thomas P, Rubinstein L. Cancer recurrence after resection: T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1990;49:242–7. PubMedCrossRef Thomas P, Rubinstein L. Cancer recurrence after resection: T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1990;49:242–7. PubMedCrossRef
9.
Zurück zum Zitat Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst. 1998;90:1335–45. PubMedCrossRef Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst. 1998;90:1335–45. PubMedCrossRef
10.
Zurück zum Zitat Deschamps C, Pairolero PC, Trastek VF, Payne WS. Multiple primary lung cancers. Results of surgical treatment. J Thorac Cardiovasc Surg. 1990;99:769–77. Discussion 777–8. PubMed Deschamps C, Pairolero PC, Trastek VF, Payne WS. Multiple primary lung cancers. Results of surgical treatment. J Thorac Cardiovasc Surg. 1990;99:769–77. Discussion 777–8. PubMed
11.
Zurück zum Zitat Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70:606–12. PubMed Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70:606–12. PubMed
12.
Zurück zum Zitat Edelman MJ, Schuetz J. Follow-up of local (stage I and stage II) non-small-cell lung cancer after surgical resection. Curr Treat Options Oncol. 2002;3(1)67–73. PubMedCrossRef Edelman MJ, Schuetz J. Follow-up of local (stage I and stage II) non-small-cell lung cancer after surgical resection. Curr Treat Options Oncol. 2002;3(1)67–73. PubMedCrossRef
13.
Zurück zum Zitat Naunheim KS, Virgo KS, Coplin MA, Johnson FE. Clinical surveillance testing after lung cancer operations. Ann Thorac Surg. 1995;60(6):1612–6. PubMedCrossRef Naunheim KS, Virgo KS, Coplin MA, Johnson FE. Clinical surveillance testing after lung cancer operations. Ann Thorac Surg. 1995;60(6):1612–6. PubMedCrossRef
14.
Zurück zum Zitat Virgo KS, Naunheim KS, Coplin MA, Johnson FE. Lung cancer patient follow-up: motivation of thoracic surgeons. Chest. 1998;114:1519–34. PubMedCrossRef Virgo KS, Naunheim KS, Coplin MA, Johnson FE. Lung cancer patient follow-up: motivation of thoracic surgeons. Chest. 1998;114:1519–34. PubMedCrossRef
15.
Zurück zum Zitat Colice GL, Rubins J, Unger M. Follow-up and surveillance of the lung cancer patient following curative-intent therapy. Chest. 2003;123:272S–83S. PubMedCrossRef Colice GL, Rubins J, Unger M. Follow-up and surveillance of the lung cancer patient following curative-intent therapy. Chest. 2003;123:272S–83S. PubMedCrossRef
16.
Zurück zum Zitat Vansteenkiste J, Crino L, Dooms C, Douillard JY, Faivre-Finn C, Lim E, Rocco G, Senan S, Van Schil P, Veronesi G, Stahel R, Peters S, Felip E. 2nd ESMO Consensus Conference on Lung Cancer: early stage non-small cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol. In press 2014. Vansteenkiste J, Crino L, Dooms C, Douillard JY, Faivre-Finn C, Lim E, Rocco G, Senan S, Van Schil P, Veronesi G, Stahel R, Peters S, Felip E. 2nd ESMO Consensus Conference on Lung Cancer: early stage non-small cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol. In press 2014.
17.
Zurück zum Zitat Colt HG, Murgu SD, Korst RJ, Slatore CG, Unger M, Quadrelli S. Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5):e437S–54S. PubMedCrossRef Colt HG, Murgu SD, Korst RJ, Slatore CG, Unger M, Quadrelli S. Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5):e437S–54S. PubMedCrossRef
20.
Zurück zum Zitat Moore S, Corner J, Haviland J, Wells M, Salmon E, Normand C, Brada M, O’Brien M, Smith I. Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial. BMJ. 2002;325(7373):1145. PubMedCentralPubMedCrossRef Moore S, Corner J, Haviland J, Wells M, Salmon E, Normand C, Brada M, O’Brien M, Smith I. Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial. BMJ. 2002;325(7373):1145. PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Virgo KS, McKirgan LW, Caputo MC, Mahurin DM, Chao LC, Caputo NA, Naunheim KS, Flye MW, Gillespie KN, Johnson FE. Post-treatment management options for patients with lung cancer. Ann Surg. 1995;222(6):700–10. PubMedCentralPubMedCrossRef Virgo KS, McKirgan LW, Caputo MC, Mahurin DM, Chao LC, Caputo NA, Naunheim KS, Flye MW, Gillespie KN, Johnson FE. Post-treatment management options for patients with lung cancer. Ann Surg. 1995;222(6):700–10. PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Nakamura R, Kurishima K, Kobayashi N, Ishikawa S, Goto Y, Sakai M, Onizuka M, Ishikawa H, Satoh H, Hizawa N, Sato Y. Postoperative follow-up for patients with non-small cell lung cancer. Onkologie. 2010;33(1–2):14–8. PubMed Nakamura R, Kurishima K, Kobayashi N, Ishikawa S, Goto Y, Sakai M, Onizuka M, Ishikawa H, Satoh H, Hizawa N, Sato Y. Postoperative follow-up for patients with non-small cell lung cancer. Onkologie. 2010;33(1–2):14–8. PubMed
23.
Zurück zum Zitat Younes RN, Gross JL. Follow-up in lung cancer how often and for what purpose? Chest. 1999;115:1494–9. PubMedCrossRef Younes RN, Gross JL. Follow-up in lung cancer how often and for what purpose? Chest. 1999;115:1494–9. PubMedCrossRef
24.
Zurück zum Zitat Egermann U, Jaeggi K, Habicht JM, Perruchoud AP, Dalquen P, Soler M. Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients? Eur Respir J. 2002;19(3):464–8. PubMedCrossRef Egermann U, Jaeggi K, Habicht JM, Perruchoud AP, Dalquen P, Soler M. Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients? Eur Respir J. 2002;19(3):464–8. PubMedCrossRef
25.
Zurück zum Zitat Walsh GL, O’Connor M, Willis KM, Milas M, Wong RS, Nesbitt JC, Putnam JB, Lee JJ, Roth JA. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg. 1995;60(6):1563–70. Discussion 1570–2. PubMedCrossRef Walsh GL, O’Connor M, Willis KM, Milas M, Wong RS, Nesbitt JC, Putnam JB, Lee JJ, Roth JA. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg. 1995;60(6):1563–70. Discussion 1570–2. PubMedCrossRef
26.
Zurück zum Zitat Westeel V, Choma D, Clément F, Woronoff-Lemsi MC, Pugin JF, Dubiez A, Depierre A. Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg. 2000;70:1185–90. PubMedCrossRef Westeel V, Choma D, Clément F, Woronoff-Lemsi MC, Pugin JF, Dubiez A, Depierre A. Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg. 2000;70:1185–90. PubMedCrossRef
27.
Zurück zum Zitat Song IH, Yeom SW, Heo S, Choi WS, Yang HC, Jheon S, Kim K, Cho S. Prognostic factors for post-recurrence survival in patients with completely resected stage I non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014;45(2):262–7. PubMedCrossRef Song IH, Yeom SW, Heo S, Choi WS, Yang HC, Jheon S, Kim K, Cho S. Prognostic factors for post-recurrence survival in patients with completely resected stage I non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014;45(2):262–7. PubMedCrossRef
28.
Zurück zum Zitat Curran WJ, Herbert SH, Stafford PM, Sandler HM, Rosenthal SA, McKenna WG, Hughes E, Dougherty MJ, Keller S. Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy? Int J Radiat Oncol Biol Phys. 1992;24:25–30. PubMedCrossRef Curran WJ, Herbert SH, Stafford PM, Sandler HM, Rosenthal SA, McKenna WG, Hughes E, Dougherty MJ, Keller S. Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy? Int J Radiat Oncol Biol Phys. 1992;24:25–30. PubMedCrossRef
30.
Zurück zum Zitat Hanna WC, Paul NS, Darling GE, Moshonov H, Allison F, Waddell TK, Cypel M, de Perrot ME, Yasufuku K, Keshavjee S, Pierre AF. Minimal-dose computed tomography is superior to chest x-ray for the follow-up and treatment of patients with resected lung cancer. J Thorac Cardiovasc Surg. 2014;147(1):30–3. PubMedCrossRef Hanna WC, Paul NS, Darling GE, Moshonov H, Allison F, Waddell TK, Cypel M, de Perrot ME, Yasufuku K, Keshavjee S, Pierre AF. Minimal-dose computed tomography is superior to chest x-ray for the follow-up and treatment of patients with resected lung cancer. J Thorac Cardiovasc Surg. 2014;147(1):30–3. PubMedCrossRef
31.
Zurück zum Zitat Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409. PubMedCrossRef Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409. PubMedCrossRef
32.
Zurück zum Zitat Weber W, Young C, Abdel-Dayem HM, Sfakianakis G, Weir GJ, Swaney CM, Gates M, Stokkel MP, Parker A, Hines H, Khanvali B, Liebig JR, Leung AN, Sollitto R, Caputo G, Wagner HN. Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras. J Nucl Med. 1999;40(4):574–8. PubMed Weber W, Young C, Abdel-Dayem HM, Sfakianakis G, Weir GJ, Swaney CM, Gates M, Stokkel MP, Parker A, Hines H, Khanvali B, Liebig JR, Leung AN, Sollitto R, Caputo G, Wagner HN. Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma cameras. J Nucl Med. 1999;40(4):574–8. PubMed
33.
Zurück zum Zitat Monteil J, Vergnenègre A, Bertin F, Dalmay F, Gaillard S, Bonnaud F, Melloni B. Randomized follow-up study of resected NSCLC patients: conventional versus 18F-DG coincidence imaging. Anticancer Res. 2010;30(9):3811–6. PubMed Monteil J, Vergnenègre A, Bertin F, Dalmay F, Gaillard S, Bonnaud F, Melloni B. Randomized follow-up study of resected NSCLC patients: conventional versus 18F-DG coincidence imaging. Anticancer Res. 2010;30(9):3811–6. PubMed
34.
Zurück zum Zitat Warren GW, Kasza KA, Reid ME, Cummings KM, Marshall JR. Smoking at diagnosis and survival in cancer patients. Int J Cancer. 2013;132(2):401–10. PubMedCrossRef Warren GW, Kasza KA, Reid ME, Cummings KM, Marshall JR. Smoking at diagnosis and survival in cancer patients. Int J Cancer. 2013;132(2):401–10. PubMedCrossRef
35.
Zurück zum Zitat Park SM, Lim MK, Jung KW, Shin SA, Yoo K-Y, Yun YH, Huh BY. Prediagnosis smoking, obesity, insulin resistance, and second primary cancer risk in male cancer survivors: National health insurance corporation study. J Clin Oncol. 2007;25(30):4835–43. PubMedCrossRef Park SM, Lim MK, Jung KW, Shin SA, Yoo K-Y, Yun YH, Huh BY. Prediagnosis smoking, obesity, insulin resistance, and second primary cancer risk in male cancer survivors: National health insurance corporation study. J Clin Oncol. 2007;25(30):4835–43. PubMedCrossRef
36.
Zurück zum Zitat Gajdos C, Hawn MT, Campagna EJ, Henderson WG, Singh JA, Houston T. Adverse effects of smoking on postoperative outcomes in cancer patients. Ann Surg Oncol. 2012;19(5):1430–8. PubMedCrossRef Gajdos C, Hawn MT, Campagna EJ, Henderson WG, Singh JA, Houston T. Adverse effects of smoking on postoperative outcomes in cancer patients. Ann Surg Oncol. 2012;19(5):1430–8. PubMedCrossRef
37.
Zurück zum Zitat Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010;340:b5569. PubMedCentralPubMedCrossRef Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010;340:b5569. PubMedCentralPubMedCrossRef
Metadaten
Titel
Follow-up in non-small-cell lung cancer
verfasst von
MD, PhD Sacha I. Rothschild
MD Didier Lardinois
MD Jens Bremerich
MD Michael Tamm
MD Lukas Bubendorf
MD Alexandros Papachristofilou
MSc Hansruedi Stoll
MD Alfred Zippelius
Publikationsdatum
01.05.2014
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 2/2014
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-014-0144-x